2024
Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk.
Murnane P, Afshar M, Chamie G, Cook R, Ferguson T, Haque L, Jacobson K, Justice A, Kim T, Khalili M, Krupitsky E, McGinnis K, Molina P, Muyindike W, Myers B, Richards V, So-Armah K, Stewart S, Sulkowski M, Tien P, Hahn J. Using phosphatidylethanol as an adjunct to self-reported alcohol use improves identification of liver fibrosis risk. The American Journal Of Gastroenterology 2024 PMID: 39480054, DOI: 10.14309/ajg.0000000000003178.Peer-Reviewed Original ResearchLiver fibrosis riskAUDIT-CFIB-4Self-reported alcohol useOdds ratioAlcohol useFibrosis riskPooled individual-level dataLiver fibrosis preventionBody mass indexAssessment of alcohol useManagement of liver diseaseOne-unit differenceIndividual-level dataMedian ageAUDIT-C.Mass indexSuppression statusLiver diseaseFibrosis preventionBlood concentrationsAdjusted modelsLogistic regressionCategorical variablesHIVA Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System
Haque L, Tate J, Chew M, Caniglia E, Taddei T, Re V. A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System. Pharmacoepidemiology And Drug Safety 2024, 33: e70024. PMID: 39477692, DOI: 10.1002/pds.70024.Peer-Reviewed Original ResearchConceptsVeterans Health Administration dataHealth administrative dataAdministrative dataElectronic health record systemsHealth record systemsInternational Classification of DiseasesCoding algorithmOutpatient International Classification of DiseasesPositive predictive valueClassification of DiseasesHepatic decompensationDiagnosis codesPharmacoepidemiologic researchMedical recordsVeteransRecording systemValidation algorithmAlgorithmChronic liver diseaseDecompensationLiver diseasePredictive valueRecordsDiagnosisEpidemiology and Health Care Burden of Alcohol Use Disorder
Choi H, Balter D, Haque L. Epidemiology and Health Care Burden of Alcohol Use Disorder. Clinics In Liver Disease 2024, 28: 577-588. PMID: 39362708, DOI: 10.1016/j.cld.2024.06.006.Peer-Reviewed Original ResearchW31 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis
Haque L, Fiellin D, Bryant K, Edelman E, Justice A, Lim J, Re V, Marshall B, Taddei T, Tate J, Tetrault J, Williams E, McGinnis K. W31 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis. Drug And Alcohol Dependence 2024, 260: 110649. DOI: 10.1016/j.drugalcdep.2023.110649.Peer-Reviewed Original ResearchIntegrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.
Haque L, Leggio L. Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder. Hepatology 2024, 80: 1408-1423. PMID: 38935926, DOI: 10.1097/hep.0000000000000996.Peer-Reviewed Original ResearchAUD careAlcohol-associated liver diseaseAlcohol use disorderCollaborative careImpact of health disparitiesAlcohol-related deathsImpact of comorbid conditionsPublic health impactUse disorderHarm reduction approachesLiver diseaseInterprofessional teamHealth disparitiesTreatment of alcohol use disordersComprehensive careProblematic alcohol useSubstance use disordersSpectrum of alcohol-associated liver diseasesTreatment gapLiver-related outcomesMinority of patientsLiver-related morbidityAlcohol use disorder treatmentCareAlcohol useAddiction and liver disease series
Haque L, Mellinger J. Addiction and liver disease series. Clinical Liver Disease 2024, 23: e0227. PMCID: PMC11164010, DOI: 10.1097/cld.0000000000000227.Peer-Reviewed Original ResearchOpportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond
Oldfield B, Haque L, Jennifer Edelman E. Opportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond. Journal Of General Internal Medicine 2024, 39: 2129-2130. PMID: 38671202, PMCID: PMC11347542, DOI: 10.1007/s11606-024-08730-w.Peer-Reviewed Original ResearchFeasibility of an Interprofessional Inpatient Educational Intervention for Patients With Decompensated Cirrhosis
Haque L, McDonough M, Deng Y, Ciarleglio M, Liapakis A, Jakab S. Feasibility of an Interprofessional Inpatient Educational Intervention for Patients With Decompensated Cirrhosis. Gastro Hep Advances 2024, 3: 615-617. PMID: 39165423, PMCID: PMC11330928, DOI: 10.1016/j.gastha.2024.03.011.Peer-Reviewed Original ResearchManagement of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities
Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque L, Balliet W, Serper M. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transplantation 2024, 30: 848-861. PMID: 38471008, DOI: 10.1097/lvt.0000000000000362.Peer-Reviewed Original ResearchAlcohol-associated liver diseaseAlcohol use disorderAUD careValue-based care modelsPrevalence of alcohol use disordersPost-LTLiver transplantationManagement of alcohol-associated liver diseasePost-transplant patient survivalLiver diseaseRisk of disease recurrenceUse disorderImprove patient outcomesPost-LT relapseCare modelSystemic barriersTherapy accessDigital healthUnmet needsLiver transplant candidatesAlcohol consumptionCenters of excellenceGlobal health burdenAddiction specialistsCareTreatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
Haque L, Zuluaga P, Muga R, Fuster D. Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction Science & Clinical Practice 2024, 19: 19. PMID: 38504384, PMCID: PMC10949674, DOI: 10.1186/s13722-024-00448-8.Peer-Reviewed Original ResearchConceptsAlcohol-associated liver diseaseAlcohol use disorderLiver diseasePresence of liver cirrhosisTreatment of alcohol use disordersUse disorderInnovative treatment strategiesUnhealthy alcohol usePharmacologic treatment choicesTreating unhealthy alcohol useLiver transplantationLiver cirrhosisTreatment strategiesTreatment choiceEfficacious treatmentLiver deathsPatientsAlcohol useDiseaseLiverTreatmentDisordersCirrhosisTransplantation
2021
Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis
Saffo S, To UK, Santoiemma PP, Laurito M, Haque L, Rabiee A, Verna EC, Angarone MP, Garcia-Tsao G. Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis. Clinical Gastroenterology And Hepatology 2021, 20: e1201-e1204. PMID: 34273564, PMCID: PMC11090177, DOI: 10.1016/j.cgh.2021.07.019.Peer-Reviewed Original ResearchMental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration
Haque L, Rosenheck R. Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration. Journal Of Public Mental Health 2021, 20: 191-200. DOI: 10.1108/jpmh-07-2020-0088.Peer-Reviewed Original ResearchVeterans Health AdministrationMental health treatmentSubstance use disordersSpecialized addiction treatmentLiver diseaseHealth treatmentAddiction treatmentMental healthHealth AdministrationUnited States Veterans Health AdministrationYears of ageDrug dependence diagnosesProportion of adultsService useUse disordersAlcohol dependenceDependence diagnosisDrug dependenceHomeless veteransVeteransTreatmentGood knowledgeComprehensive servicesHigh rateDisease
2020
Budd-Chiari Syndrome An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed
Haque LYK, Lim JK. Budd-Chiari Syndrome An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed. Clinics In Liver Disease 2020, 24: 453-481. PMID: 32620283, DOI: 10.1016/j.cld.2020.04.012.BooksConceptsBudd-Chiari syndromeLiver diseaseHepatic venous outflow obstructionPrimary Budd-Chiari syndromeDevelopment of cirrhosisVenous outflow obstructionChronic liver diseaseLife-threatening diagnosisVariable clinical presentationPortal hypertensionProthrombotic stateVenous obstructionLifelong anticoagulationMost patientsOutflow obstructionUncommon causeClinical presentationRare causeRisk factorsHepatocellular carcinomaHigh indexPatientsDiseaseSyndromeObstruction
2019
PRO: Older Adults Should Be Offered Liver Transplantation
Haque L, Palumbo CS, Batisti J. PRO: Older Adults Should Be Offered Liver Transplantation. Clinical Liver Disease 2019, 14: 66-69. PMID: 31508223, PMCID: PMC6726385, DOI: 10.1002/cld.821.BooksNational Trends in Use of Opioid Drugs Among Cirrhosis-related Hospitalizations in the United States, 2004 to 2012
McCarty TR, Haque L, Njei B. National Trends in Use of Opioid Drugs Among Cirrhosis-related Hospitalizations in the United States, 2004 to 2012. Journal Of Clinical Gastroenterology 2019, 53: 78-79. PMID: 27984400, DOI: 10.1097/mcg.0000000000000771.Peer-Reviewed Original Research
2018
A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe
Haque L, Villanueva M, Russo A, Yuan Y, Lee EJ, Topal J, Podoltsev N. A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe. PLOS Neglected Tropical Diseases 2018, 12: e0006727. PMID: 30286207, PMCID: PMC6171829, DOI: 10.1371/journal.pntd.0006727.Peer-Reviewed Case Reports and Technical NotesConceptsVisceral leishmaniasisHealthy travelersRare caseEndemic areasEndemic visceral leishmaniasisSuccessful initial treatmentLiposomal amphotericin BBone marrow biopsyImmunocompetent adultsImmunocompetent travelersNight sweatsImmunocompetent individualsInitial treatmentMarrow biopsyRelapseAmphotericin BPreventive measuresLeishmaniasisTreatmentUnited StatesExtensive experiencePancytopeniaSplenomegalyBiopsyPatientsCannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Njei B, Sharma P, McCarty TR, Singh M, Haque L, Aslanian HR, Jamidar P, Muniraj T. Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2018, 47: 1142-1149. PMID: 30134357, DOI: 10.1097/mpa.0000000000001143.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisIncidence risk ratioCholangiopancreatography pancreatitisCannabis useRisk of PEPEndoscopic retrograde cholangiopancreatography pancreatitisUS Nationwide Inpatient SampleRate of PEPShorter hospital stayNationwide Inpatient SampleNinth Edition codesImpact of cannabisPoisson regression modelsHospital deathHospital stayIndependent predictorsEdition codesRisk ratioInpatient SampleInternational ClassificationMultivariate analysisPancreatitisPatientsCannabisSignificant increaseResponse to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012
McCarty TR, Echouffo-Tcheugui JB, Lange A, Haque L, Njei B. Response to letter to the editor: impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012. Surgery For Obesity And Related Diseases 2018, 14: 726. PMID: 29576483, DOI: 10.1016/j.soard.2018.02.020.Commentaries, Editorials and Letters
2017
Cannabis Use Disorder Is Associated With Increased Risk of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: Analysis of the U.S. Nationwide Inpatient Sample (NIS) Database, 2004-2014
Njei B, McCarty T, Sharma P, Singh M, Haque L, Aslanian H, Jamidar P, Muniraj T. Cannabis Use Disorder Is Associated With Increased Risk of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: Analysis of the U.S. Nationwide Inpatient Sample (NIS) Database, 2004-2014. The American Journal Of Gastroenterology 2017, 112: s19. DOI: 10.14309/00000434-201710001-00040.Peer-Reviewed Original ResearchImpact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012
McCarty TR, Echouffo-Tcheugui JB, Lange A, Haque L, Njei B. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012. Surgery For Obesity And Related Diseases 2017, 14: 74-80. PMID: 29055669, DOI: 10.1016/j.soard.2017.09.511.Peer-Reviewed Original ResearchConceptsNonalcoholic fatty liver diseasePrior bariatric surgeryBariatric surgeryFatty liver diseaseIncidence risk ratioNAFLD patientsMorbid obesityRenal failureClinical outcomesLiver diseaseMyocardial infarctionRisk ratioNationwide Inpatient Sample AnalysisNationwide Inpatient Sample databaseObese NAFLD patientsOutcomes of patientsBariatric surgery proceduresMorbidly obese individualsPopulation-based dataHospital mortalityHospital morbidityInpatient mortalitySecondary outcomesHospitalized patientsPrimary outcome